Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8507

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,507 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
YGG Yggdrazil Group	฿0.62	-6.1%	-91.5%	฿373.2m	฿10.75	PS1.7x	E87.1%	43.2%	Media
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م3.30	-11.1%	28.4%	ج.م5.0b	ج.م5.18	PE18.6x	E30.7%	2.0%	Pharmaceuticals & Biotech
FWRY Fawry for Banking Technology and Electronic PaymentsE	ج.م8.16	-2.9%	43.7%	ج.م27.8b	ج.م12.45	PE22.5x	E27.4%	n/a	Diversified Financials
AFISH Arctic Fish Holding	NOK 67.50	2.3%	12.5%	NOK 2.2b	NOK 81.00	PE66.5x	E65.4%	n/a	Food, Beverage & Tobacco
AGP Altea Green Power	€5.10	-5.4%	-32.4%	€88.3m	€12.40	PE13x	E23.3%	n/a	Capital Goods
ICOP I.CO.P.. Società Benefit	€8.28	5.9%	n/a	€228.8m	€9.80	PE45.3x	E49.2%	n/a	Capital Goods
AOT Ascot Resources	CA$0.14	-21.6%	-73.1%	CA$142.3m	CA$0.45	PS9.9x	E79.5%	n/a	Materials
ONON On Holding	US$53.97	-7.5%	80.1%	US$17.8b	US$62.62	PE125.2x	E29.7%	n/a	Consumer Durables
ZVRA Zevra Therapeutics	US$7.54	-7.3%	30.9%	US$401.9m	US$20.75	PS16.4x	E57.2%	n/a	Pharmaceuticals & Biotech
NVDA NVIDIA	US$132.80	11.9%	84.1%	US$3.3t	US$172.08	PE51.6x	E21.6%	0.03%	Semiconductors
LITE Lumentum Holdings	US$79.60	-7.8%	67.3%	US$5.7b	US$100.00	PS3.9x	E118.6%	n/a	Tech
CDR CD Projekt	zł224.30	4.4%	105.2%	zł22.4b	zł161.82	PE51x	E39.4%	0.4%	Media
KINS Kingstone Companies	US$17.32	-3.1%	428.9%	US$215.2m	US$18.00	PE13.5x	E24.9%	0%	Insurance
ARES Ares Management	US$186.37	-4.6%	38.1%	US$59.5b	US$198.36	PE85.3x	E41.6%	2.4%	Diversified Financials
TVTX Travere Therapeutics	US$23.75	12.6%	197.2%	US$1.8b	US$31.20	PS10.2x	E61.7%	n/a	Pharmaceuticals & Biotech
RCEL AVITA Medical	US$8.70	-5.0%	-48.7%	US$232.6m	US$17.08	PS3.8x	E51.9%	n/a	Pharmaceuticals & Biotech
ALKT Alkami Technology	US$33.74	-5.0%	33.8%	US$3.5b	US$45.10	PS10.7x	E102.7%	n/a	Software
PRL Propel Holdings	CA$37.07	-3.7%	127.1%	CA$1.5b	CA$45.92	PE23.3x	E38.9%	1.6%	Diversified Financials
TGTX TG Therapeutics	US$31.11	-5.5%	123.3%	US$4.6b	US$40.33	PS16.9x	E45.2%	n/a	Pharmaceuticals & Biotech
LAVV3 Lavvi Empreendimentos Imobiliários	R$8.67	0%	12.3%	R$1.8b	R$12.63	PE5.5x	E22.8%	3.3%	Real Estate Management and Development
GAU Galiano Gold	CA$1.79	6.5%	43.2%	CA$457.6m	CA$3.12	PS1.9x	E65.4%	n/a	Materials
ALNY Alnylam Pharmaceuticals	US$268.99	-0.7%	66.0%	US$35.3b	US$299.74	PS16.6x	E56.7%	n/a	Pharmaceuticals & Biotech
AXSM Axsome Therapeutics	US$132.20	17.1%	43.3%	US$6.2b	US$152.00	PS18.9x	E58.2%	n/a	Pharmaceuticals & Biotech
SFPTECH SFP Tech Holdings Berhad	RM 0.62	-8.1%	-29.9%	RM 1.5b	RM 0.96	PE38.8x	E28.3%	0.6%	Capital Goods

Page 1 of 355